SS
KYNB

SBI Securities’s Kyntra Bio KYNB Stock Holding History

SBI Securities’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Hold
152
– – ﹤0.01% 2757
2026
Q1 		$1.03K Hold
152
– – ﹤0.01% 2645
2025
Q4 		$1.33K Hold
152
– – ﹤0.01% 2538
2025
Q3 		$1.86K Hold
152
– – ﹤0.01% 2447
2025
Q2 		$806 Buy
152
+59
+63% +$430 ﹤0.01% 2769
2025
Q1 		$721 Buy
93
+64
+221% +$767 ﹤0.01% 2731
2024
Q4 		$382 Buy
+29
New +$269 ﹤0.01% 2992

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

SBI Securities's KYNB Position: Q2 2026 in Review

SBI Securities held its Kyntra Bio (KYNB) position steady in Q2 2026 at 152 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

SBI Securities first reported a position in KYNB in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.86K in Q3 2025. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • SBI Securities held 152 shares of Kyntra Bio worth $1.15K as of Q2 2026.
  • SBI Securities left its Kyntra Bio share count unchanged in Q2 2026.
  • Kyntra Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2757 holding.
  • SBI Securities first reported a position in Kyntra Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Kyntra Bio position peaked at $1.86K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.